According to a new market report published by Lucintel, the future of the genome editing market looks promising with opportunities in cell line engineering, animal genetic engineering, and plant genetic engineering applications. The global genome editing market is expected to grow with a CAGR of 17.5% from 2020 to 2025. The major drivers for this market are rising government funding and growth in the number of genomics projects and expanding application areas of genomics.
To download report brochure, please go to https://www.lucintel.com/genome-editing-market.aspx and click "download brochure" tab from the menu
The genome editing process involves extraction of desired gene sequence, editing the gene and insertion of the modified gene into the host. In this market, CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats), TALENS (Transcription Activator-Like Effector Nucleases), and ZFN (Zinc Finger Nucleases) are the major technologies. Lucintel forecasts that CRISPR will remain the largest technology segment over the forecast period, as it can be tailored to treat patient-specific mutations for genetic diseases.
Within this market, biotechnology & pharmaceutical companies will remain the largest end use segment over the forecast period due to the large number of research projects carried out in gene engineering for the development of novel therapeutics.
North America will remain the largest region over the forecast period due to higher adoption of advanced techniques in the research institutes based in the US and higher incidence of monogenic diseases in the region.
Thermo Fisher Scientific, Merck, Horizon Discovery, Lonza, GenScript, Eurofins Scientific, and Sangamo Therapeutics are among the major suppliers in the global genome editing market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global genome editing market by technology, delivery method, application, service, end use, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Genome Editing Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global genome editing market by technology, delivery method, application, service, end use, and region as follows:
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats)
TALENS (Transcription Activator-Like Effector Nucleases)
ZFN (Zinc Finger Nucleases)
Others
By Delivery Method [Value ($ Million) shipment analysis for 2014 – 2025]:
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Other Applications
By Service [Value ($ Million) shipment analysis for 2014 – 2025]:
By End Use [Value ($ Million) shipment analysis for 2014 – 2025]:
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Spain
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.